BBT vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals significant concerns with a weak Piotroski F-Score of 4/9, indicating marginal financial health, and a missing Altman Z-Score prevents a full distress risk assessment. Despite a seemingly attractive Price/Book of 0.98 and a high dividend yield of 4.40%, the company is plagued by negative operating margins (-35.62%), collapsing revenue growth (-32.20% YoY), and an unsustainably high payout ratio of 600%. While analysts maintain a 'buy' recommendation with a target price above current levels, deteriorating profitability, insider selling, and a bearish technical trend contradict this optimism. The stock trades at a massive premium to its Graham Number ($11.65) and intrinsic value ($1.47), suggesting severe overvaluation relative to fundamentals.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BBT vs JPM: Head-to-Head Comparison
This page compares Beacon Financial Corporation (BBT) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.